In this Issue
Are You Part of the Renaissance?
Chief Medical Editor’s Page
By Ted E. Feldman, MD, MSCAI, FACC, FESC
Duane Pinto, MD, MPH, shares his insight on how changing from femoral to radial access might affect your pharmacologic choices at your institution.
Preserving radial patency after transradial catheterization procedures.
By Sameer Gupta, MD, and Sandeep Nathan, MD, MSc
How to address challenges that may occur with this outcome-improving access procedure.
By Daniel H. Steinberg, MD
An examination of the data on bleeding complications shows that the femoral access route remains a reasonable choice during PCI.
By Nevin C. Baker, DO, and Ron Waksman, MD
A strategic imperative for high-performing hospital systems.
By Denise Brown and Ginger Biesbrock, PA-C, MPH
With Ian C. Gilchrist, MD, FSCAI; Kimberly Skelding, MD, FACC, FAHA, FSCAI; and Jennifer A. Tremmel, MD, MS
FEATURED TECHNOLOGYSponsored by Boston Scientific Corporation
A look at the background of renal denervation studies and the future directions of this therapy for patients with hypertension.
With Krishna Rocha-Singh, MD; Farrell O. Mendelsohn, MD; and Ajay J. Kirtane, MD, SM, FACC, FSCAI
VALVE UPDATE: MITRAL
A review of devices in development for the percutaneous treatment of mitral regurgitation.
By Jonathan Marvin Tobis, MD, and Islam Abudayyeh, MD, MPH
How to predict and manage stent thrombosis and the effect of newer-generation DES.
By Donald E. Cutlip, MD
Realizing the potential benefits that can be gained when clinical pathways are implemented post-TAVR.
By Christopher U. Meduri, MD, MPH; Vivek Rajagopal, MD; Jim Kauten, MD; Charles Brown IV, BA; David Alexander, PA; Edvin K. Feldt, MD; and Brian J. Potter, MD, MSc
ASK THE ATHERECTOMY EXPERTSponsored by Cardiovascular Systems, Inc.
With Jeffrey Moses, MD
A preview of today's new products.
The newly inducted President of SCAI discusses what’s ahead for the society during the next year, challenges with current health care policy, and why he’s an enthusiastic radialist.